Literature DB >> 9865979

Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections.

S Natsch1, B J Kullberg, J W van der Meer, J F Meis.   

Abstract

The interval from the time of admission to the emergency room until the administration of antibiotics in patients presenting with a serious infectious disease was analysed. Fifty patients presumptively diagnosed in the emergency room as having a serious infection (respiratory tract, urinary tract, erysipelas, fever with neutropenia or bacteremia) needing immediate empirical antibiotic treatment were enrolled in the study. A median interval from time of admission to administration of antibiotics of 5 hours was determined (range 0.6-13.3 h). The interval was significantly shorter in patients admitted at night than in patients admitted during office hours (3.7 vs. 6.0 h, P< 0.05). There was no difference with respect to the presenting features, body temperature, laboratory values at presentation or number of cultures performed. In 41 of the 50 patients blood samples were taken for culture. More than 80% of the patients received an antibiotic chosen in accordance with hospital guidelines. The analysis revealed that the median delay of 5 hours before patients received their initial dose of antibiotic depended on several factors. Attempts to provide optimal antimicrobial therapy should thus concentrate not only on the correct choice and dosage of a drug but also on prompt institution of therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865979     DOI: 10.1007/s100960050160

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

Review 1.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  Early antimicrobial therapy in severe sepsis and septic shock.

Authors:  Anand Kumar
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

3.  Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections.

Authors:  A J H Cremers; F Hagen; P W M Hermans; J F Meis; G Ferwerda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-22       Impact factor: 3.267

4.  Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis.

Authors:  D Szwajcer; P Czaykowski; D Turner
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

5.  Effects of a pharmacist-to-dose computerized request on promptness of antimicrobial therapy.

Authors:  William R Vincent; Craig A Martin; P Shane Winstead; Kelly M Smith; Jennifer Gatz; Daniel A Lewis
Journal:  J Am Med Inform Assoc       Date:  2008-10-24       Impact factor: 4.497

6.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

7.  Time to Administration of Antibiotics among Inpatients with Severe Sepsis or Septic Shock.

Authors:  Katie Mok; Michael D Christian; Sandra Nelson; Lisa Burry
Journal:  Can J Hosp Pharm       Date:  2014-05

Review 8.  An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.

Authors:  Anand Kumar
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

Review 9.  Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.

Authors:  H Bryant Nguyen; Anja Kathrin Jaehne; Namita Jayaprakash; Matthew W Semler; Sara Hegab; Angel Coz Yataco; Geneva Tatem; Dhafer Salem; Steven Moore; Kamran Boka; Jasreen Kaur Gill; Jayna Gardner-Gray; Jacqueline Pflaum; Juan Pablo Domecq; Gina Hurst; Justin B Belsky; Raymond Fowkes; Ronald B Elkin; Steven Q Simpson; Jay L Falk; Daniel J Singer; Emanuel P Rivers
Journal:  Crit Care       Date:  2016-07-01       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.